SCHEMBL18039965

SCHEMBL18039965

C=CCOC(=O)N1CCN(C(=O)N2CCOCC2)CC1c1cc(N(C)c2ccc(Cl)s2)n(C(=O)c2cscn2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18039768 0.88 F2 (0.37) —
SCHEMBL18039967 0.85 F2 (0.41) —
SCHEMBL18040013 0.83 PKM (0.33) —
SCHEMBL18039992 0.82 PKM (0.36) —
SCHEMBL18039893 0.81 PKM (0.36) —
SCHEMBL18039730 0.81 PKM (0.36) —
SCHEMBL18040058 0.80 AKR1C3 (0.31) —
SCHEMBL18040035 0.79 PKM (0.35) —
SCHEMBL18039915 0.78 PKM (0.37) —
SCHEMBL29905847 0.78 F2 (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3261639-B1 SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS VERSEON INT CORPORATION (US) 2022-08-24 — — EP disclosed
US-20200109132-A1 SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS VERSEON INTERNATIONAL CORPORATION 2020-04-09 — — US disclosed
US-20180237421-A1 SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS VERSEON INTERNATIONAL CORPORATION 2018-08-23 — — US disclosed
EP-3261639-A1 SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS Verseon Corporation (US) 2018-01-03 — — EP disclosed
WO-2016138532-A1 SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS VERSEON CORPORATION (US) 2016-09-01 — — WO disclosed
Send feedback